Table 2.
Baseline characteristics and CMR parameters in ARVC patients with and without adverse cardiac event.
| ARVC/D with events (N = 17) | ARVC/D without events (N = 43) | P value | |
|---|---|---|---|
| Clinical data | |||
| Follow-up (Y) | 3.57 (1.60) | 4.16 (1.82) | 0.227 |
| Age (Y) | 44.12 (19.15) | 36.60 (16.78) | 0.168 |
| Male, n (%) | 11 (65) | 25 (58) | 0.773 |
| Hypertension, n (%) | 2 (18) | 2 (6) | 0.393 |
| Diabetes, n (%) | 0 | 2 (6) | 1.000 |
| History of syncope | 9 (53) | 2 (5) | 0.000 |
| ICD | 6 (35) | 1 (2) | 0.001 |
| Family history of ARVC | 2 (12) | 2 (5) | 0.317 |
| Family history of SCD | 0 | 0 | — |
| NYHA III – IV, n (%) | 9 (53) | 10 (23) | 0.035 |
| CMR conditional parameters | |||
| LVEDV, ml/m2 | 78.40 (21.08) | 63.37 (25.17) | 0.166 |
| LVESV, ml/m2 | 42.43 (14.85) | 34.79 (14.19) | 0.074 |
| LVSV, ml/m2 | 39.61 (15.17) | 37.73 (15.25) | 0.669 |
| LVEF, % | 49.57 (12.08) | 54.83 (10.11) | 0.124 |
| RVEF, % | 33.83 (12.11) | 35.51 (13.94) | 0.647 |
| Fatty infiltration, n (%) | 3 (18) | 7 (16) | 1.000 |
| LGE, n (%) | 14 (82) | 20 (47) | 0.019 |
| LV involvement on CMR | 15 (88) | 20 (47) | 0.004 |
| Feature tacking parameters | |||
| LV GRS, % | 28.53 (9.64) | 36.98 (12.06) | 0.013 |
| LV GCS, % | −13.72 (3.48) | −16.42 (3.09) | 0.010 |
| LV GLS, % | −12.07 (3.81) | −14.62 (2.75) | 0.005 |
Note: Values are mean (SD) or n (%) as appropriate.
Abbreviations: ICD, implantable cardioverter-defibrillator; SCD, sudden cardiac death; NYHA, New York Heart Association; all the other abbreviations are the same as Table 1.